From Our Partners
Wednesday, June 29, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biosecurity

Grants for Enhanced Surveillance for New Vaccine Preventable Diseases

by Global Biodefense Staff
November 30, 2015
Influenza Vaccines

Credit: Shutterstock

The U.S. Centers for Disease Control and Prevention are soliciting grant applications to support enhanced surveillance for new vaccine preventable diseases.

The effort will fund a network of pediatric medical institutions conducting prospective, active surveillance for acute gastroenteritis (AGE) and acute respiratory illnesses (ARI) in inpatient and emergency department clinical settings, and among asymptomatic healthy controls.

Funded activities for this award will include:

  • Provision of a US pediatric vaccine-preventable disease surveillance system
  • Evaluations of vaccine effectiveness for licensed vaccines including rotavirus and influenza
  • Burden and natural history of disease for pathogens having upcoming and/or new vaccines
  • Pediatric infectious disease transmission dynamics
  • Informing vaccination/therapeutic policy and development
  • Vaccine impacts for targeted and vulnerable populations
  • Socioeconomic and microbiological environments relevant to these public health interventions

A second purpose of this announcement is to prospectively follow a birth cohort to the second birthday to incorporate a natural history study of pathogens and immunologic factors related to symptomatic and asymptomatic infection in US infants. This second activity will be a separate Optional Component of the application, independently scored, that will be awarded to an applicant that has been competitively awarded a Core Component award.

The funding is open to state and local governments, academic, not-for-profits, and Federally Funded Research and Development Centers (FFRDCs).

Further details are available via Funding Opportunity Number: CDC-RFA-IP-16-004. The application deadline is Jan 15, 2016.

From Our Partners
Tags: Request for ProposalsVaccines

Related Posts

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies
Biosurveillance

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control
Medical Countermeasures

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Biodefense Industry News
Industry News

Tonix Pharmaceuticals Opens Advanced Development Center for Vaccine Programs

June 20, 2022
Dual Use Research of Concern: NIH to Host Stakeholder Engagement Meeting on Oversight Policies
Biosecurity

Dual Use Research of Concern: NIH to Host Stakeholder Engagement Meeting on Oversight Policies

June 14, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC